April 1, 2024
Protected: 1Q24 Tools & Dx Preview – Apr. 1st – REPLAY
March 26, 2024
Protected: Outlook for FDA Oversight of LDTs with Expert Jeff Gibbs – Mar 26th – REPLAY
March 11, 2024
Protected: REPLAY: Lawsuit Opens New Front Against PBM Business Practices – Mar. 8th
March 8, 2024
Protected: REPLAY: Nephron Legends: Shawn Morris, Former CEO HealthSpring and Privia – Mar. 4th
February 27, 2024
Protected: Update on Drug Price Controls & PBMs – Feb. 27th – REPLAY
February 14, 2024
Med Tech and Healthcare Services Matchmaker – 10 Deal Ideas for 2024
February 7, 2024
Protected: Takeaways from the Boston AF Symposium – Feb. 6th – REPLAY
January 29, 2024
Protected: Nephron Research Tools Update – Jan 29th – REPLAY
January 25, 2024
Protected: Decoding Device Reimbursement Controversies – Jan. 25th – Replay –
January 16, 2024
Protected: Nephron’s JPM Conference Recap – Jan. 16th – REPLAY
January 16, 2024
Protected: 340B Drug Discounts & Patient Eligibility Legal & Legislative Outlook – Jan. 16th – REPLAY
December 15, 2023
Protected: China KOL Call – Dec. 11th – REPLAY
December 15, 2023
Protected: Nephron Research 2024 Outlook – Dec. 14th – REPLAY
December 15, 2023
Protected: Exploring Acquisition Cost-Based Pharmacy & PBM Models – Dec. 14th – REPLAY
December 15, 2023
Protected: MA Annual Enrollment Period Update – Dec. 13th – REPLAY